Evidence map›Paper›PMID 21416543›Full record

ArticleProtein science : a publication of the Protein Society2011

A preferred AMPK phosphorylation site adjacent to the inhibitory loop of cardiac and skeletal troponin I.

Raquel Sancho Solis, Ying Ge, Jeffery W Walker

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Article
  7. Article
  8. Review
  9. The art of the deal in myofilament modulation of function.Journal of molecular and cellular cardiology · 2014
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Raquel Sancho SolisDepartment of Physiology, School of Medicine and Public Health, University of Wisconsin-Madison, WI 53706, USA.
Ying Ge
Jeffery W Walker
University of Wisconsin–Madison · USUniversity of Arizona · US

Funding

Novel Protein Kinase C Isoforms in Ventricular MyocytesR01HL081386 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI GREGORIO, CAROL C · 2005 to 2009
$1.6M
NHLBI NIH HHS R01 HL081386NHLBI NIH HHS R01 HL081386-06
6 · The paper itself

Abstract

5'-AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that is activated when cellular AMP to ATP ratios rise, potentially serving as a key regulator of cellular energetics. Among the known targets of AMPK are catabolic and anabolic enzymes, but little is known about the ability of this kinase to phosphorylate myofilament proteins and thereby regulating the contractile apparatus of striated muscles. Here, we demonstrate that troponin I isoforms of cardiac (cTnI) and fast skeletal (fsTnI) muscles are readily phosphorylated by AMPK. For cTnI, two highly conserved serine residues were identified as AMPK sites using a combination of high-resolution top-down electron capture dissociation mass spectrometry, (32) P-incorporation, synthetic peptides, phospho-specific antibodies, and site-directed mutagenesis. These AMPK sites in cTnI were Ser149 adjacent to the inhibitory loop and Ser22 in the cardiac-specific N-terminal extension, at the level of cTnI peptides, the intact cTnI subunit, whole cardiac troponin complexes and skinned cardiomyocytes. Phosphorylation time-course experiments revealed that Ser149 was the preferred site, because it was phosphorylated 12-16-fold faster than Ser22 in cTnI. Ser117 in fsTnI, analogous to Ser149 in cTnI, was phosphorylated with similar kinetics as cTnI Ser149. Hence, the master energy-sensing protein AMPK emerges as a possibly important regulator of cardiac and skeletal contractility via phosphorylation of a preferred site adjacent to the inhibitory loop of the thin filament protein TnI.

Indexed as

AMP-Activated Protein KinasesAnimalsBinding SitesBlotting, WesternHumansKineticsMiceMuscle, SkeletalMyocytes, CardiacPhosphorylationRatsRecombinant ProteinsSerineTroponin CTroponin TAMP-Activated Protein KinasesPRKAA1 protein, humanRecombinant ProteinsSerineTroponin CTroponin T

Identifiers

PMID21416543
PMCPMC3125873
OpenAlexW2158407655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.